Katarzyna Pierzchala1, Nicolas Kunz1, and Rolf Gruetter1
1CIBM, EPFL, Lausanne, Switzerland
Synopsis
There is increasing need of a more human cell model to recapitulate the in-vivo cell-cell interactions,
presenting physiological relevance. Magnetic resonance spectroscopy (MRS) has
the potential to diagnose many tumors and to characterize their metastatic
potential. In this study we present the metabolic profile of highly metastatic
human melanoma cells line WM793.We demonstrate the feasibility of
characterizing in-vitro living melanoma cells by
1H-MRS with a total number of 9 metabolites quantified, covering energy markers
(Glc, Lac, Ace), amino acids (Glu, Ala) and anti-oxidant (Tau, Asc) and cell
membrane precursor (Cho).Abstract
There is
increasing need of a more human cell model to recapitulate the
in-vivo
cell-cell interactions, presenting physiological relevance. Unraveling the cell molecular interactions of
complex molecular machines in their cellular context is of prime importance for
understanding fundamental physiological processes and bridge the gap between
animal models and human clinical trials. In this context human 3D in-vitro
models have a potential for pre-clinical research. Magnetic resonance
spectroscopy (MRS) of intact living cells gives the possibility to revile
information about cell-cell and cell-extracellular matrix (ECM) interactions. [1,2]. The carcinogenic process, i.e. transform into tumor
cells leads to intracellular changes, such as immortalization, independence of
growth signals and metabolic changes. These significantly modify the
intracellular and the tumor microenvironment [3]. Physiological processes rely on the concerted action of molecular
entities in and across different cellular compartments. MRS has the
potential to diagnose many tumors and to characterize their metastatic
potential. Therefore
the meaning of intensity changes of MRS signals associated to cells metabolism is
of fundamental importance. With this respect, studies in intact cultured cells
that maintain cells under controlled conditions are a unique tool for high-lighting
aspects of metabolism.
In this study we present the metabolic profile of
highly metastatic human melanoma cells line WM793.
Materials
and methods
For
in-vitro MRS, the studied melanoma cells WM793 were grown in 75cm2
TC flasks (Sarstedt) at 37oC in 95% humidified air containing 5% CO2
incubator. The applied culture medium
was RPMI1640 (pH 7.4, Sigma), supplemented with 10% of Fetal Bovine Serum
(Sigma) and 1% of antibiotics (50.5 units/ml penicillin, 50.5μg/ml
streptomycin and 101μg/ml neomycin, Sigma). Cells were trypsinized to detach
as a thin tissue layer from flask, transferred into 15mL tube and
centrifuged at 2000 RPM for 2min. The trypsin supernatant was removed and
cells quasi pellet was transferred into the designed setup. The tube with cells
was filled within the RPMI (Fig 1).
All experiments were performed on
a 9.4T/26cm horizontal
magnet with a 12cm gradient coil insert (400mT/m,120µs)(Varian/Agilent). A home-built single loop surface
coil of 15mm-diameter
was used as transceiver. Localization of the living cell was performed with a
fast spin-echo image and used to place the 1H-MRS acquisition voxel (Fig 2).
Spectroscopy was acquired with the SPECIAL sequence [4] in a 2.5x4x5mm3 voxel with
the following parameters (TE/TR=2.8/4000ms, 400 averages). Vapor water
suppression as outer volume suppression module were applied. Field inhomogeneity was corrected using the
FASTMAP protocol. The acquisition time was of 25min. Spectrum was quantified using LCModel using water
signal as reference.
Results
The proposed procedure with an acquisition
time of 25min allowed to acquire high quality spectra with S/N=26 and line
width of 6Hz measured on the water resonance (Fig. 3). The relatively short
acquisition time is believed to minimize the eventual exposure of cells to high
hypoxia environment.
Peaks
of metabolites characteristic for dividing cells populations, like choline and
amino acids such as alanine, glutamate, taurine, and lactate were detected in
addition to the metabolism of glucose, acetate, ascorbate and macromolecules (Table 1).
A
few resonances were not clearly identified in this preliminary study, with
peaks at 3.45, 3.82 and 3.87, which may correspond to glycogen. Further investigations are required to establish the true nature of these
signals.
Metabolites
detected in this study were also reported by Bacchi
et al. in their experiment on the lyophilized extracts from Tm1 murine melanoma cells [5].
These primary
results encourage us to continue investigation of
in-vitro living cells MRS study
and to go further for primary cells line from eradicated
tumors of clinical patients. Furthermore this method allows us to perform
investigation on experimental treatments with for example anticancer drug by
monitoring the change of metabolites level.
Conclusions
We demonstrate the feasibility of characterizing
in-vitro living melanoma cells by 1H-MRS. A total number of 9 metabolites were
quantified in the study, covering energy markers (Glc, Lac, Ace), amino acids
(Glu, Ala) and anti-oxidant (Tau, Asc) and cell membrane precursor (Cho).
In-vitro living cells MRS is believed to provide new
insight on the characterization of cancer and also to help in conception of
treatments.
Acknowledgements
Supported by the CIBM of the UNIL, UNIGE, HUG, CHUV, EPFL, Leenards and Jeantet foundationReferences
1. Miller G: Is pharma running out of brainy ideas? Science 2010,
329:502-504.
2. Pampaloni F, Reynaud EG, Stelzer EHK: The third dimension bridges the
gap
between cell culture and live tissue. Nat Rev
Mol Cell Biol 2007, 8:839-845.
3. Hanahan D,
Weinberg R (2011) Hallmarks of Cancer: The Next Generation. Cell 144:646-674
4. Mlynárik V, Gambarota G, Frenkel H, Gruetter R. Localized short-echo-time proton MR
spectroscopy with full signal-intensity acquisition. Magn Reson Med. 2006
Nov;56(5):965-70.
5.Bacchi P, Bloise A, Bustos S, Zimmermann, Chammas and Rabbani S:
Metabolism
under hypoxia in Tm1 murine melanoma cells is affected by the presence of
galectin-3, a metabolomics approach.SpringerPlus 2014,
3:470